Renal Mass and Localized Renal Cancer: AUA Guideline

Steven Campbell, Robert G. Uzzo, Mohamad E. Allaf, Eric B. Bass, Jeffrey A Cadeddu, Anthony Chang, Peter E. Clark, Brian J. Davis, Ithaar H. Derweesh, Leo Giambarresi, Debra A. Gervais, Susie L. Hu, Brian R. Lane, Bradley C. Leibovich, Philip M. Pierorazio

Research output: Contribution to journalArticle

304 Citations (Scopus)

Abstract

Purpose This AUA Guideline focuses on evaluation/counseling and management of adult patients with clinically localized renal masses suspicious for cancer, including solid-enhancing tumors and Bosniak 3/4 complex-cystic lesions. Materials and Methods Systematic review utilized research from the Agency for Healthcare Research and Quality and additional supplementation by the authors and consultant methodologists. Evidence-based statements were based on body of evidence strength Grade A/B/C (Strong/Moderate/Conditional Recommendations, respectively) with additional statements presented as Clinical Principles or Expert Opinions. Results Great progress has been made since the previous guidelines on management of localized renal masses were released (2009). The current guidelines provide updated, evidence-based recommendations regarding evaluation/counseling of patients with clinically localized renal masses, including the evolving role of renal mass biopsy. Given great variability of clinical, oncologic and functional characteristics, index patients are not utilized and the panel advocates individualized counseling/management. Management options (partial nephrectomy/radical nephrectomy/thermal ablation/active surveillance) are reviewed including recent data about comparative effectiveness and potential morbidities. Oncologic issues are prioritized while recognizing that functional outcomes are of great importance for survivorship for most patients with localized kidney cancer. A more restricted role for radical nephrectomy is recommended following well-defined selection criteria. Priority for partial nephrectomy is recommended for clinical T1a lesions, along with selective use of thermal ablation, particularly for tumors ≤3.0 cm. Important considerations for shared decision-making about active surveillance are explicitly defined. Conclusions Several factors should be considered during counseling/management of patients with clinically localized renal masses, including general health/comorbidities, oncologic potential of the mass, pertinent functional issues and relative efficacy/potential morbidities of various management strategies.

Original languageEnglish (US)
Pages (from-to)520-529
Number of pages10
JournalJournal of Urology
Volume198
Issue number3
DOIs
StatePublished - Sep 1 2017

Fingerprint

Kidney Neoplasms
Nephrectomy
Guidelines
Counseling
Kidney
Hot Temperature
Morbidity
Neoplasms
Health Services Research
Expert Testimony
Consultants
Patient Selection
Comorbidity
Decision Making
Survival Rate
Biopsy
Health
Research

Keywords

  • ablation techniques
  • kidney diseases
  • kidney neoplasms
  • nephrectomy
  • watchful waiting

ASJC Scopus subject areas

  • Urology

Cite this

Campbell, S., Uzzo, R. G., Allaf, M. E., Bass, E. B., Cadeddu, J. A., Chang, A., ... Pierorazio, P. M. (2017). Renal Mass and Localized Renal Cancer: AUA Guideline. Journal of Urology, 198(3), 520-529. https://doi.org/10.1016/j.juro.2017.04.100

Renal Mass and Localized Renal Cancer : AUA Guideline. / Campbell, Steven; Uzzo, Robert G.; Allaf, Mohamad E.; Bass, Eric B.; Cadeddu, Jeffrey A; Chang, Anthony; Clark, Peter E.; Davis, Brian J.; Derweesh, Ithaar H.; Giambarresi, Leo; Gervais, Debra A.; Hu, Susie L.; Lane, Brian R.; Leibovich, Bradley C.; Pierorazio, Philip M.

In: Journal of Urology, Vol. 198, No. 3, 01.09.2017, p. 520-529.

Research output: Contribution to journalArticle

Campbell, S, Uzzo, RG, Allaf, ME, Bass, EB, Cadeddu, JA, Chang, A, Clark, PE, Davis, BJ, Derweesh, IH, Giambarresi, L, Gervais, DA, Hu, SL, Lane, BR, Leibovich, BC & Pierorazio, PM 2017, 'Renal Mass and Localized Renal Cancer: AUA Guideline', Journal of Urology, vol. 198, no. 3, pp. 520-529. https://doi.org/10.1016/j.juro.2017.04.100
Campbell S, Uzzo RG, Allaf ME, Bass EB, Cadeddu JA, Chang A et al. Renal Mass and Localized Renal Cancer: AUA Guideline. Journal of Urology. 2017 Sep 1;198(3):520-529. https://doi.org/10.1016/j.juro.2017.04.100
Campbell, Steven ; Uzzo, Robert G. ; Allaf, Mohamad E. ; Bass, Eric B. ; Cadeddu, Jeffrey A ; Chang, Anthony ; Clark, Peter E. ; Davis, Brian J. ; Derweesh, Ithaar H. ; Giambarresi, Leo ; Gervais, Debra A. ; Hu, Susie L. ; Lane, Brian R. ; Leibovich, Bradley C. ; Pierorazio, Philip M. / Renal Mass and Localized Renal Cancer : AUA Guideline. In: Journal of Urology. 2017 ; Vol. 198, No. 3. pp. 520-529.
@article{d681d4ebb3e14e90a3b88525007c4ca5,
title = "Renal Mass and Localized Renal Cancer: AUA Guideline",
abstract = "Purpose This AUA Guideline focuses on evaluation/counseling and management of adult patients with clinically localized renal masses suspicious for cancer, including solid-enhancing tumors and Bosniak 3/4 complex-cystic lesions. Materials and Methods Systematic review utilized research from the Agency for Healthcare Research and Quality and additional supplementation by the authors and consultant methodologists. Evidence-based statements were based on body of evidence strength Grade A/B/C (Strong/Moderate/Conditional Recommendations, respectively) with additional statements presented as Clinical Principles or Expert Opinions. Results Great progress has been made since the previous guidelines on management of localized renal masses were released (2009). The current guidelines provide updated, evidence-based recommendations regarding evaluation/counseling of patients with clinically localized renal masses, including the evolving role of renal mass biopsy. Given great variability of clinical, oncologic and functional characteristics, index patients are not utilized and the panel advocates individualized counseling/management. Management options (partial nephrectomy/radical nephrectomy/thermal ablation/active surveillance) are reviewed including recent data about comparative effectiveness and potential morbidities. Oncologic issues are prioritized while recognizing that functional outcomes are of great importance for survivorship for most patients with localized kidney cancer. A more restricted role for radical nephrectomy is recommended following well-defined selection criteria. Priority for partial nephrectomy is recommended for clinical T1a lesions, along with selective use of thermal ablation, particularly for tumors ≤3.0 cm. Important considerations for shared decision-making about active surveillance are explicitly defined. Conclusions Several factors should be considered during counseling/management of patients with clinically localized renal masses, including general health/comorbidities, oncologic potential of the mass, pertinent functional issues and relative efficacy/potential morbidities of various management strategies.",
keywords = "ablation techniques, kidney diseases, kidney neoplasms, nephrectomy, watchful waiting",
author = "Steven Campbell and Uzzo, {Robert G.} and Allaf, {Mohamad E.} and Bass, {Eric B.} and Cadeddu, {Jeffrey A} and Anthony Chang and Clark, {Peter E.} and Davis, {Brian J.} and Derweesh, {Ithaar H.} and Leo Giambarresi and Gervais, {Debra A.} and Hu, {Susie L.} and Lane, {Brian R.} and Leibovich, {Bradley C.} and Pierorazio, {Philip M.}",
year = "2017",
month = "9",
day = "1",
doi = "10.1016/j.juro.2017.04.100",
language = "English (US)",
volume = "198",
pages = "520--529",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Renal Mass and Localized Renal Cancer

T2 - AUA Guideline

AU - Campbell, Steven

AU - Uzzo, Robert G.

AU - Allaf, Mohamad E.

AU - Bass, Eric B.

AU - Cadeddu, Jeffrey A

AU - Chang, Anthony

AU - Clark, Peter E.

AU - Davis, Brian J.

AU - Derweesh, Ithaar H.

AU - Giambarresi, Leo

AU - Gervais, Debra A.

AU - Hu, Susie L.

AU - Lane, Brian R.

AU - Leibovich, Bradley C.

AU - Pierorazio, Philip M.

PY - 2017/9/1

Y1 - 2017/9/1

N2 - Purpose This AUA Guideline focuses on evaluation/counseling and management of adult patients with clinically localized renal masses suspicious for cancer, including solid-enhancing tumors and Bosniak 3/4 complex-cystic lesions. Materials and Methods Systematic review utilized research from the Agency for Healthcare Research and Quality and additional supplementation by the authors and consultant methodologists. Evidence-based statements were based on body of evidence strength Grade A/B/C (Strong/Moderate/Conditional Recommendations, respectively) with additional statements presented as Clinical Principles or Expert Opinions. Results Great progress has been made since the previous guidelines on management of localized renal masses were released (2009). The current guidelines provide updated, evidence-based recommendations regarding evaluation/counseling of patients with clinically localized renal masses, including the evolving role of renal mass biopsy. Given great variability of clinical, oncologic and functional characteristics, index patients are not utilized and the panel advocates individualized counseling/management. Management options (partial nephrectomy/radical nephrectomy/thermal ablation/active surveillance) are reviewed including recent data about comparative effectiveness and potential morbidities. Oncologic issues are prioritized while recognizing that functional outcomes are of great importance for survivorship for most patients with localized kidney cancer. A more restricted role for radical nephrectomy is recommended following well-defined selection criteria. Priority for partial nephrectomy is recommended for clinical T1a lesions, along with selective use of thermal ablation, particularly for tumors ≤3.0 cm. Important considerations for shared decision-making about active surveillance are explicitly defined. Conclusions Several factors should be considered during counseling/management of patients with clinically localized renal masses, including general health/comorbidities, oncologic potential of the mass, pertinent functional issues and relative efficacy/potential morbidities of various management strategies.

AB - Purpose This AUA Guideline focuses on evaluation/counseling and management of adult patients with clinically localized renal masses suspicious for cancer, including solid-enhancing tumors and Bosniak 3/4 complex-cystic lesions. Materials and Methods Systematic review utilized research from the Agency for Healthcare Research and Quality and additional supplementation by the authors and consultant methodologists. Evidence-based statements were based on body of evidence strength Grade A/B/C (Strong/Moderate/Conditional Recommendations, respectively) with additional statements presented as Clinical Principles or Expert Opinions. Results Great progress has been made since the previous guidelines on management of localized renal masses were released (2009). The current guidelines provide updated, evidence-based recommendations regarding evaluation/counseling of patients with clinically localized renal masses, including the evolving role of renal mass biopsy. Given great variability of clinical, oncologic and functional characteristics, index patients are not utilized and the panel advocates individualized counseling/management. Management options (partial nephrectomy/radical nephrectomy/thermal ablation/active surveillance) are reviewed including recent data about comparative effectiveness and potential morbidities. Oncologic issues are prioritized while recognizing that functional outcomes are of great importance for survivorship for most patients with localized kidney cancer. A more restricted role for radical nephrectomy is recommended following well-defined selection criteria. Priority for partial nephrectomy is recommended for clinical T1a lesions, along with selective use of thermal ablation, particularly for tumors ≤3.0 cm. Important considerations for shared decision-making about active surveillance are explicitly defined. Conclusions Several factors should be considered during counseling/management of patients with clinically localized renal masses, including general health/comorbidities, oncologic potential of the mass, pertinent functional issues and relative efficacy/potential morbidities of various management strategies.

KW - ablation techniques

KW - kidney diseases

KW - kidney neoplasms

KW - nephrectomy

KW - watchful waiting

UR - http://www.scopus.com/inward/record.url?scp=85025076086&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85025076086&partnerID=8YFLogxK

U2 - 10.1016/j.juro.2017.04.100

DO - 10.1016/j.juro.2017.04.100

M3 - Article

C2 - 28479239

AN - SCOPUS:85025076086

VL - 198

SP - 520

EP - 529

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 3

ER -